Franco Poletti - 15 Sep 2025 Form 4 Insider Report for LivaNova PLC (LIVN)

Role
President, Cardiopulmonary
Signature
/s/ Sarah K. Mohr, Attorney-in-Fact
Issuer symbol
LIVN
Transactions as of
15 Sep 2025
Net transactions value
-$15,354
Form type
4
Filing time
17 Sep 2025, 16:05:35 UTC
Previous filing
01 Apr 2025
Next filing
17 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Poletti Franco President, Cardiopulmonary 20 EASTBOURNE TERRACE, LONDON, UNITED KINGDOM /s/ Sarah K. Mohr, Attorney-in-Fact 17 Sep 2025 0002031281

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LIVN Ordinary Shares Options Exercise $0 +643 +8.1% $0.000000 8,576 15 Sep 2025 Direct F1
transaction LIVN Ordinary Shares Tax liability $15,354 -277 -3.2% $55.43 8,299 15 Sep 2025 Direct F2
holding LIVN Ordinary Shares 219 15 Sep 2025 By Spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LIVN Restricted Stock Units Options Exercise $0 -643 -25% $0.000000 1,932 15 Sep 2025 Ordinary Shares 643 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reporting person had vested restricted stock units ("RSUs") settled in ordinary shares of LivaNova PLC (the "Company"), GBP 1.00 par value.
F2 Shares withheld to satisfy tax liability.
F3 Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2022 Incentive Award Plan (the "Plan") and the award agreement.
F4 On September 15, 2024, reporting person was granted RSUs subject to a four-year vesting in equal annual installments. The first vesting occurred on September 15, 2025. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement.